Reports for OLMESARTAN MEDOXOMIL
Ingredient
OLMESARTAN MEDOXOMIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-OLMESARTAN | 20MG | TABLET | Resolved | 2019-05-09 | 2019-11-15 | 83720 |
| PMS-OLMESARTAN | 20MG | TABLET | Resolved | 2019-11-28 | 2020-11-24 | 99861 |
| PMS-OLMESARTAN | 20MG | TABLET | Resolved | 2019-12-24 | 2020-11-24 | 102000 |
| OLMESARTAN | 20MG | TABLET | Resolved | 2023-07-31 | 2024-01-17 | 200465 |
| OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-03-11 | 2024-03-11 | 221869 |
| AURO-OLMESARTAN | 20MG | TABLET | Resolved | 2019-05-28 | 2021-03-31 | 85093 |
| AURO-OLMESARTAN | 20MG | TABLET | Actual shortage | 2023-07-21 | 2024-04-16 | 199665 |
| SANDOZ OLMESARTAN | 20MG | TABLET | Resolved | 2017-11-14 | 2018-05-23 | 29204 |
| SANDOZ OLMESARTAN | 20MG | TABLET | Resolved | 2018-02-05 | 2018-04-19 | 38739 |
| SANDOZ OLMESARTAN | 20MG | TABLET | Resolved | 2019-04-10 | 2020-08-24 | 80934 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLMESARTAN / HCTZ | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| PMS-OLMESARTAN | 20MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149385 |
| AURO-OLMESARTAN | 20MG | TABLET | Discontinued | 2023-11-21 | 2023-11-22 | 210984 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| RIVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2019-04-17 | 2019-04-18 | 81926 |
| TEVA-OLMESARTAN / HCTZ | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| TEVA-OLMESARTAN / HCTZ | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| PMS-OLMESARTAN | 40MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149388 |
| AURO-OLMESARTAN | 40MG | TABLET | Discontinued | 2023-11-21 | 2023-11-22 | 210987 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |